home.aspx
 
EVENTS

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Axentis Pharma AG

SHARESHARESHARE
Axentis Pharma AG is a Swiss-based pharmaceutical company focused on value-added anti-infectives in combination with novel inhalation devices. Following the entrance of a License Agreement with a Japanese partner, Axentis Pharma engaged in the development of AX-TOBRA, a liposome-based drug-device combination to combat chronic lung diseases and respiratory disorders, especially cystic fibrosis. AX-TOBRA received Orphan Designations from EU-EMA and US-FDA. To protect Axentis Pharma against loss and damage from malversations caused by its Japanese partner, Axentis Pharma initiated arbitration proceedings in Tokyo, and, ultimately, won a final and binding Arbitration Award against its former partner. The award was issued by the Japan Commercial Arbitration Association (JCAA) in Tokyo in August 2013. Currently, Axentis Pharma is seeking to enforce the Arbitration Award through judicial remedies.
SHARESHARESHARE

RELATED NEWS


The UK government has outlined how it will ensure the supply of medicines continues in the event of a “no deal” Brexit, urging companies to stockpile six weeks’ worth of medicine. With the March 2019 Brexit deadline looming ever closer, there are mounting concerns that the UK will be unable to reach an agreement over the country’s future relationship with the EU. Although the government is insisting this is unlikely, it has published a series of documents to help business...

READ MORE

In this live session, entitled 'pharmaceutical serialization for late starters', Carlos Machado, serialization director at SEA Vision US and Paolo Landriani, product manager at SEA Vision Italy will offer insight on how companies within the pharmaceutical industry can prepare for upcoming serialization regulations, with a view to guaranteeing long term success and compliance....

READ MORE

At the National University of Singapore, scientists have developed a portable, point-of-care nucleic acid test platform that can be used to diagnose a variety of diseases. It comes in the form of a cartridge that does not need to be kept refrigerated or handled specially in any other way and once used it provides results faster than existing methods. Called enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids), the testing device has everything needed to perform the...
NATIONAL UNIVERSITY OF SINGAPORE
READ MORE

Artificial intelligence technology has an established home in drug design for many developers. Now, researchers are seeing it as a potential tool in driving therapeutic choices in the treatment of ovarian cancer. Researchers in the United Kingdom used artificial intelligence technology to analyze tissue samples of 514 ovarian cancer patients. The AI technology was used to carefully identify and track the shape of about 150 million different cells in total, Forbes reported. Yinyin Yuan, the team ...

READ MORE

After months of wrangling, the EMA finally has a solution to the £500 million financial liability it has faced over the tenancy to its former home in Canary Wharf. The EU regulator – now based in temporary accommodation in Amsterdam – has sub-let the entire 284,704 square feet (26,450 m2)accommodation at 30 Churchill Place to WeWork, a fast-growing shared office-space group. As a result of the deal, the EMA has also now settled its litigation with the Canary Wharf Group. Faced ...

READ MORE

U.S. regulators Friday approved the first drug to reduce nighttime trips to the bathroom. The treatment is a nasal spray intended for adults who wake up at least twice a night to urinate....

READ MORE

EVENTS

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...